LRRK2 Monoclonal Antibody

$Lane 1: Mouse brain tissue lysates probed with LRRK2 Monoclonal Antibody, Unconjugated (bsm-51545M) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.$

Lane 1: Mouse brain tissue lysates probed with LRRK2 Monoclonal Antibody, Unconjugated (bsm-51545M) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.

Applications

WB
IHC-P
IHC-F
IF

Predicted Reactivity

Human
Mouse

Overview
Catalog #	bsm-51545m
Product Name	LRRK2 Monoclonal Antibody
Applications	WB, IHC-P, IHC-F, IF
Predicted Reactivity	Human, Mouse
Specifications
Conjugation	Unconjugated
Host	Mouse
Source	Recombinant human PARK8 (LRRK2) (Fragment) (His-tagged).
Clonality	Monoclonal
Clone #	#REF!
Isotype	IgG1
Concentration	0.5ug/ul
Storage Buffer	0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage Condition	Shipped at 4_. Store at -20_ for one year. Avoid repeated freeze/thaw cycles.
Target
Gene ID	120892
Swiss Prot	Q5S007
Subcellular location	Cytoplasm, Cell membrane
Synonyms	Dardarin; Leucine rich repeat kinase 2; LRRK 2; LRRK-2; PARK 8; PARK8; ROCO 2; ROCO-2; ROCO2; Leucine-rich repeat serine/threonine-protein kinase 2; Dardarin; LRRK2_HUMAN; augmented in rheumatoid arthritis 17; AURA17; Leucine rich repeat kinase 2; RIPK7.
Background	May play a role in the phosphorylation of proteins central to Parkinson disease. Phosphorylates PRDX3. May also have GTPase activity.
Application Dilution
WB	=1:500-1000
IHC-P	IHC-P=1:100-500
IHC-F	IHC-F=1:400-800
IF	IF=1:50-200